Abstract
Skin changes play an important role in the course of anticancer therapy and in the dispensarisation of the patients with malignant tumours. The article briefly discusses the cutaneous complications in these patients.
The text summarizes the risk of development of another primary cutaneous malignant tumour, the development of cutaneous or subcutaneous metastases and carcinomatous lymphadenopathy, cutaneous paraneoplastic syndromes, the adverse effects of the anticancer therapy and finally the cutaneous complications related to the disease progression. Particular attention is devoted to the specific types of cutaneous metastases, to the obligatory paraneoplastic syndromes, to cutaneous toxicity of immunotherapy and to complications of radiotherapy.
The correct education of the patient is an important aspect of the success of the anticancer therapy. Because of it the patient could early recognize the signs of adverse effects of the anticancer therapy or the signs of disease progression.